Cita APA

Casajús, A., Zubiaur, P., Méndez, M., Campodónico, D., Gómez, A., Navares-Gómez, M., . . . Abad Santos, F. (2022). Genotype-Guided prescription of Azathioprine reduces the incidence of adverse drug reactions in TPMT intermediate metabolizers to a similar incidence as normal metabolizers.

Citación estilo Chicago

Casajús, Ana, et al. Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence As Normal Metabolizers. 2022.

Cita MLA

Casajús, Ana, et al. Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence As Normal Metabolizers. 2022.